Michael D. McGoon

Mayo Clinic in Arizona — United States

Medicine · Health Sciences

81h-index41.1kcitations245works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(174), Cardiovascular Function and Risk Factors(45), Cardiovascular Issues in Pregnancy(38), Vascular Anomalies and Treatments(29), Cardiac Valve Diseases and Treatments(22)

Publications245 total

Predicting Survival in Patients With Pulmonary Arterial Hypertension
CHEST Journal·2019· 609 citedOpen Access
The importance of patient perspectives in pulmonary hypertension
European Respiratory Journal·2018· 118 citedOpen Access
Response
CHEST Journal·2018Open Access
Thrombocytopenia independently predicts death in idiopathic PAH
Heart & Lung·2018· 16 cited
Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL
The Journal of Heart and Lung Transplantation·2018· 28 citedOpen Access
Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension
CHEST Journal·2018· 57 citedOpen Access
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis
The Journal of Heart and Lung Transplantation·2017· 48 citedOpen Access
The prognostic significance of tricuspid valve regurgitation in pulmonary arterial hypertension
The Clinical Respiratory Journal·2017· 51 cited
Using controlled and real-world data in concert to assess survival benefits in pulmonary arterial hypertension: Insights from SERAPHIN and REVEAL
2017· 1 cited
Updated Risk Score Calculator for Pulmonary Arterial Hypertension Patients
The Journal of Heart and Lung Transplantation·2017· 13 cited
Characterization of Prostacyclin-associated Leg Pain in Patients with Pulmonary Arterial Hypertension
Annals of the American Thoracic Society·2017· 12 cited
A Cross-Sectional Assessment of Adherence to Expert Consensus Diagnosis and Treatment Guidelines by Comprehensive Care Centers Accredited by the Pulmonary Hypertension Association
CHEST Journal·2016· 1 citedOpen Access
Impact of age on pulmonary artery systolic pressures at rest and with exercise
Echo Research and Practice·2016· 44 citedOpen Access
The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress
European Respiratory Journal·2015· 78 citedOpen Access
Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia
CHEST Journal·2015· 35 cited
Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
CHEST Journal·2015· 501 citedOpen Access
Validation of two predictive models for survival in pulmonary arterial hypertension
European Respiratory Journal·2015· 98 citedOpen Access
ELECTROCARDIOGRAPHIC CHARACTERISTICS OF PULMONARY HYPERTENSION IN THE SETTING OF HEREDITARY HEMORRHAGIC TELANGIECTASIA
Journal of the American College of Cardiology·2015
Pulmoner arter hipertansiyonunun güncel tedavi algoritması
2014
Pulmoner arter hipertansiyonu: Epidemiyoloji ve kayıtlar
2014
page 1 of 13Next →

Frequent Co-authors

David B. Badesch(20), Robyn J. Barst(16), Adaani Frost(15), Lewis J. Rubin(12), Dave P. Miller(11), Vallerie V. McLaughlin(10), Harrison W. Farber(8), Raymond L. Benza(8), Victor F. Tapson(7), Robert P. Frantz(7), C. Gregory Elliott(7), Horst Olschewski(7), Ronald J. Oudiz(7), Stuart Rich(5), Michelle Turner(5), Nazzareno Galiè(5), Robert C. Bourge(4), Aimee J. Foreman(4), Theodore G. Liou(4), Ivan M. Robbins(4)